Longevity/mortality Buy-Ins, Buy-Outs, Longevity Bonds, Pandemics

Analysis

The PRA's David Rule on Brexit, the risk margin and the regulator's hotspots for supervision in 2018

The UK’s executive director for insurance supervision talks to Christopher Cundy about how the Prudential Regulation Authority is approaching Brexit and reveals the latest views on reforming the risk margin

Lapse risk takes centre stage in capital management strategies

Since the introduction of Solvency II, EU life insurers have had to hold much more capital against the risk of customers lapsing their policies. Luca Tres explains how innovative hedging structures can help firms maximise their capital efficiency

Swiss Re's Dan Ryan: UK moratorium on genetic testing will have to change

Dan Ryan, head of research at the Swiss Re Institute, talks to Cintia Cheong about the rise of genetic testing, life insurtech, and why insurers and academics need to work together to understand mortality trends

NN's Jan-Hendrik Erasmus: "the key issue is how to embrace technology"

NN Group’s chief risk officer discusses with David Walker how the Dutch insurer is positioned for M&A, why Solvency II does not need to change, longevity risk hedging and today’s technology and cyber challenges

Gen Re's Jules Constantinou: technology can make insurance more meaningful

Jules Constantinou, regional manager for life and health at GenRe UK and Ireland, and president-elect of the Institute and Faculty of Actuaries, vows to make insurance more meaningful to society. He tells Cintia Cheong how technology can help achieve that

Declining UK influence suggests far-reaching Solvency II reforms

National supervisors argue that looming reviews of the standard formula and the long-term guarantees package could be wider than expected now the UK has voted to leave the EU. Hugo Coelho reports

More Longevity/mortality Analysis >